Trials / Recruiting
RecruitingNCT03364296
Biological Dating of Cerebral Ischemia With GST-π/PRDX1 to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis
Biological Dating of Cerebral Ischemia With Glutathion S-Transferase-π (GST-π) and Peroxyredoxin 1 (PRDX1) to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 930 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The FLAG1 study will assess the diagnostic performance of biomarkers Glutathion S-Transferase-π (GST-π) and Peroxyredoxin 1 (PRDX1) to identify cerebral infarction of less than 4,5 hours in a population of patients with neurological deficiency of less than 12 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Samples | Blood sample retrieved for biological assessment and biobanking |
Timeline
- Start date
- 2018-10-15
- Primary completion
- 2024-09-13
- Completion
- 2025-03-01
- First posted
- 2017-12-06
- Last updated
- 2024-05-17
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03364296. Inclusion in this directory is not an endorsement.